The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hemostasis and Tissue Sealing Agents Market Research Report 2024

Global Hemostasis and Tissue Sealing Agents Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1386141

No of Pages : 99

Synopsis
Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.
Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.
The global Hemostasis and Tissue Sealing Agents market was valued at US$ 3559.5 million in 2023 and is anticipated to reach US$ 4961.4 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent is about 64%.
Hemostasis and Tissue Sealing Agents is widely used for Minimally Invasive Surgery, General Surgery and other field. The most proportion of Hemostasis and Tissue Sealing Agents is used for general surgery, and the proprotion is 44%.
North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is not intense. Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution and Pfizer, etc. are the leaders of the industry, with about 70% market shares.
This report aims to provide a comprehensive presentation of the global market for Hemostasis and Tissue Sealing Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostasis and Tissue Sealing Agents.
Report Scope
The Hemostasis and Tissue Sealing Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostasis and Tissue Sealing Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostasis and Tissue Sealing Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
Segment by Type
Hemostasis Agents
Tissue Sealing Agents
Segment by Application
Minimally Invasive Surgery
General Surgery
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostasis and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostasis and Tissue Sealing Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Hemostasis and Tissue Sealing Agents Market Overview
1.1 Product Overview and Scope of Hemostasis and Tissue Sealing Agents
1.2 Hemostasis and Tissue Sealing Agents Segment by Type
1.2.1 Global Hemostasis and Tissue Sealing Agents Market Value Comparison by Type (2024-2030)
1.2.2 Hemostasis Agents
1.2.3 Tissue Sealing Agents
1.3 Hemostasis and Tissue Sealing Agents Segment by Application
1.3.1 Global Hemostasis and Tissue Sealing Agents Market Value by Application: (2024-2030)
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Others
1.4 Global Hemostasis and Tissue Sealing Agents Market Size Estimates and Forecasts
1.4.1 Global Hemostasis and Tissue Sealing Agents Revenue 2019-2030
1.4.2 Global Hemostasis and Tissue Sealing Agents Sales 2019-2030
1.4.3 Global Hemostasis and Tissue Sealing Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostasis and Tissue Sealing Agents Market Competition by Manufacturers
2.1 Global Hemostasis and Tissue Sealing Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostasis and Tissue Sealing Agents Average Price by Manufacturers (2019-2024)
2.4 Global Hemostasis and Tissue Sealing Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostasis and Tissue Sealing Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostasis and Tissue Sealing Agents, Product Type & Application
2.7 Hemostasis and Tissue Sealing Agents Market Competitive Situation and Trends
2.7.1 Hemostasis and Tissue Sealing Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostasis and Tissue Sealing Agents Players Market Share by Revenue
2.7.3 Global Hemostasis and Tissue Sealing Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostasis and Tissue Sealing Agents Retrospective Market Scenario by Region
3.1 Global Hemostasis and Tissue Sealing Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostasis and Tissue Sealing Agents Global Hemostasis and Tissue Sealing Agents Sales by Region: 2019-2030
3.2.1 Global Hemostasis and Tissue Sealing Agents Sales by Region: 2019-2024
3.2.2 Global Hemostasis and Tissue Sealing Agents Sales by Region: 2025-2030
3.3 Global Hemostasis and Tissue Sealing Agents Global Hemostasis and Tissue Sealing Agents Revenue by Region: 2019-2030
3.3.1 Global Hemostasis and Tissue Sealing Agents Revenue by Region: 2019-2024
3.3.2 Global Hemostasis and Tissue Sealing Agents Revenue by Region: 2025-2030
3.4 North America Hemostasis and Tissue Sealing Agents Market Facts & Figures by Country
3.4.1 North America Hemostasis and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostasis and Tissue Sealing Agents Sales by Country (2019-2030)
3.4.3 North America Hemostasis and Tissue Sealing Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostasis and Tissue Sealing Agents Market Facts & Figures by Country
3.5.1 Europe Hemostasis and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostasis and Tissue Sealing Agents Sales by Country (2019-2030)
3.5.3 Europe Hemostasis and Tissue Sealing Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostasis and Tissue Sealing Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostasis and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostasis and Tissue Sealing Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostasis and Tissue Sealing Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostasis and Tissue Sealing Agents Market Facts & Figures by Country
3.7.1 Latin America Hemostasis and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostasis and Tissue Sealing Agents Sales by Country (2019-2030)
3.7.3 Latin America Hemostasis and Tissue Sealing Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostasis and Tissue Sealing Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostasis and Tissue Sealing Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostasis and Tissue Sealing Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostasis and Tissue Sealing Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostasis and Tissue Sealing Agents Sales by Type (2019-2030)
4.1.1 Global Hemostasis and Tissue Sealing Agents Sales by Type (2019-2024)
4.1.2 Global Hemostasis and Tissue Sealing Agents Sales by Type (2025-2030)
4.1.3 Global Hemostasis and Tissue Sealing Agents Sales Market Share by Type (2019-2030)
4.2 Global Hemostasis and Tissue Sealing Agents Revenue by Type (2019-2030)
4.2.1 Global Hemostasis and Tissue Sealing Agents Revenue by Type (2019-2024)
4.2.2 Global Hemostasis and Tissue Sealing Agents Revenue by Type (2025-2030)
4.2.3 Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Type (2019-2030)
4.3 Global Hemostasis and Tissue Sealing Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostasis and Tissue Sealing Agents Sales by Application (2019-2030)
5.1.1 Global Hemostasis and Tissue Sealing Agents Sales by Application (2019-2024)
5.1.2 Global Hemostasis and Tissue Sealing Agents Sales by Application (2025-2030)
5.1.3 Global Hemostasis and Tissue Sealing Agents Sales Market Share by Application (2019-2030)
5.2 Global Hemostasis and Tissue Sealing Agents Revenue by Application (2019-2030)
5.2.1 Global Hemostasis and Tissue Sealing Agents Revenue by Application (2019-2024)
5.2.2 Global Hemostasis and Tissue Sealing Agents Revenue by Application (2025-2030)
5.2.3 Global Hemostasis and Tissue Sealing Agents Revenue Market Share by Application (2019-2030)
5.3 Global Hemostasis and Tissue Sealing Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Hemostasis and Tissue Sealing Agents Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter Hemostasis and Tissue Sealing Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 C R Bard
6.3.1 C R Bard Corporation Information
6.3.2 C R Bard Description and Business Overview
6.3.3 C R Bard Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 C R Bard Hemostasis and Tissue Sealing Agents Product Portfolio
6.3.5 C R Bard Recent Developments/Updates
6.4 B Braun
6.4.1 B Braun Corporation Information
6.4.2 B Braun Description and Business Overview
6.4.3 B Braun Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B Braun Hemostasis and Tissue Sealing Agents Product Portfolio
6.4.5 B Braun Recent Developments/Updates
6.5 Gelita
6.5.1 Gelita Corporation Information
6.5.2 Gelita Description and Business Overview
6.5.3 Gelita Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Gelita Hemostasis and Tissue Sealing Agents Product Portfolio
6.5.5 Gelita Recent Developments/Updates
6.6 Integra Life Sciences
6.6.1 Integra Life Sciences Corporation Information
6.6.2 Integra Life Sciences Description and Business Overview
6.6.3 Integra Life Sciences Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Integra Life Sciences Hemostasis and Tissue Sealing Agents Product Portfolio
6.6.5 Integra Life Sciences Recent Developments/Updates
6.7 Advance Medical Solution
6.6.1 Advance Medical Solution Corporation Information
6.6.2 Advance Medical Solution Description and Business Overview
6.6.3 Advance Medical Solution Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Advance Medical Solution Hemostasis and Tissue Sealing Agents Product Portfolio
6.7.5 Advance Medical Solution Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Hemostasis and Tissue Sealing Agents Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 CSL Behring
6.9.1 CSL Behring Corporation Information
6.9.2 CSL Behring Description and Business Overview
6.9.3 CSL Behring Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSL Behring Hemostasis and Tissue Sealing Agents Product Portfolio
6.9.5 CSL Behring Recent Developments/Updates
6.10 CryoLife
6.10.1 CryoLife Corporation Information
6.10.2 CryoLife Description and Business Overview
6.10.3 CryoLife Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CryoLife Hemostasis and Tissue Sealing Agents Product Portfolio
6.10.5 CryoLife Recent Developments/Updates
6.11 Zimmer Biomet
6.11.1 Zimmer Biomet Corporation Information
6.11.2 Zimmer Biomet Hemostasis and Tissue Sealing Agents Description and Business Overview
6.11.3 Zimmer Biomet Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zimmer Biomet Hemostasis and Tissue Sealing Agents Product Portfolio
6.11.5 Zimmer Biomet Recent Developments/Updates
6.12 Ferrosan Medical Devices
6.12.1 Ferrosan Medical Devices Corporation Information
6.12.2 Ferrosan Medical Devices Hemostasis and Tissue Sealing Agents Description and Business Overview
6.12.3 Ferrosan Medical Devices Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ferrosan Medical Devices Hemostasis and Tissue Sealing Agents Product Portfolio
6.12.5 Ferrosan Medical Devices Recent Developments/Updates
6.13 Medtronic
6.13.1 Medtronic Corporation Information
6.13.2 Medtronic Hemostasis and Tissue Sealing Agents Description and Business Overview
6.13.3 Medtronic Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Medtronic Hemostasis and Tissue Sealing Agents Product Portfolio
6.13.5 Medtronic Recent Developments/Updates
6.14 Smith & Nephew
6.14.1 Smith & Nephew Corporation Information
6.14.2 Smith & Nephew Hemostasis and Tissue Sealing Agents Description and Business Overview
6.14.3 Smith & Nephew Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Smith & Nephew Hemostasis and Tissue Sealing Agents Product Portfolio
6.14.5 Smith & Nephew Recent Developments/Updates
6.15 Z-Medica
6.15.1 Z-Medica Corporation Information
6.15.2 Z-Medica Hemostasis and Tissue Sealing Agents Description and Business Overview
6.15.3 Z-Medica Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Z-Medica Hemostasis and Tissue Sealing Agents Product Portfolio
6.15.5 Z-Medica Recent Developments/Updates
6.16 Cohera Medical
6.16.1 Cohera Medical Corporation Information
6.16.2 Cohera Medical Hemostasis and Tissue Sealing Agents Description and Business Overview
6.16.3 Cohera Medical Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Cohera Medical Hemostasis and Tissue Sealing Agents Product Portfolio
6.16.5 Cohera Medical Recent Developments/Updates
6.17 Marine Polymer
6.17.1 Marine Polymer Corporation Information
6.17.2 Marine Polymer Hemostasis and Tissue Sealing Agents Description and Business Overview
6.17.3 Marine Polymer Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Marine Polymer Hemostasis and Tissue Sealing Agents Product Portfolio
6.17.5 Marine Polymer Recent Developments/Updates
6.18 Equimedical
6.18.1 Equimedical Corporation Information
6.18.2 Equimedical Hemostasis and Tissue Sealing Agents Description and Business Overview
6.18.3 Equimedical Hemostasis and Tissue Sealing Agents Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Equimedical Hemostasis and Tissue Sealing Agents Product Portfolio
6.18.5 Equimedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostasis and Tissue Sealing Agents Industry Chain Analysis
7.2 Hemostasis and Tissue Sealing Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostasis and Tissue Sealing Agents Production Mode & Process
7.4 Hemostasis and Tissue Sealing Agents Sales and Marketing
7.4.1 Hemostasis and Tissue Sealing Agents Sales Channels
7.4.2 Hemostasis and Tissue Sealing Agents Distributors
7.5 Hemostasis and Tissue Sealing Agents Customers
8 Hemostasis and Tissue Sealing Agents Market Dynamics
8.1 Hemostasis and Tissue Sealing Agents Industry Trends
8.2 Hemostasis and Tissue Sealing Agents Market Drivers
8.3 Hemostasis and Tissue Sealing Agents Market Challenges
8.4 Hemostasis and Tissue Sealing Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’